Study | Objectives | No. of subjects | The area under the ROC curve | Sensitivity | Specificity | Best model | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RS | CM | COM | RS | CM | COM | RS | CM | COM | ||||
Ma et al. [56] | Preoperative prediction of MVI | 157 (T:110, V: 47) | 0.793 | 0.761 | 0.801 | 0.656 | 0.944 | 0.889 | 0.944 | 0.655 | 0.759 | COM |
Yang et al. [41] | Prediction of MVI | 208 (T: 146, V: 62) | 0.837 | 0.759 | 0.861 | 0.842 | 0.737 | 0.895 | 0.744 | 0.674 | 0.814 | COM |
Xu et al. [29] | Prediction of MVI and survival | 495 (T:350, V:145) | 0.806 | N/A | 0.889 | 0.755 | 0.653 | 0.898 | 0.719 | 0.760 | 0.792 | COM |
Zhang et al. [57] | Prediction of MVI | 267 (T:194, V:73) | 0.820 | 0.721 | 0.858 | 0.692 | 0.269 | 0.808 | 0.809 | 0.936 | 0.861 | COM |
Zhu et al. [58] | Prediction of MVI | 142 (T:99, V:43) | 0.773 | N/A | 0.794 | 0.750 | N/A | 0.812 | 0.815 | N/A | 0.852 | COM |
Zhang et al. [59] | Prediction of early recurrence | 155 (T:108, V:47) | 0.728 | 0.814 | 0.841 | 0.696 | 0.783 | 0.913 | 0.708 | 0.833 | 0.750 | COM |
Zhou et al. [60] | Prediction of early recurrence | 215 | 0.817 | 0.781 | 0.708 | 0.794 | 0.784 | 0.824 | 0.699 | 0.619 | 0.708 | COM |